We investigated the effects of different concentrations of PCI34051 (3, 10, and 30 mg/kg bodyweight/day), an HDAC8 selective inhibitor, on concomitant cardiac hypertrophy using the TAC-induced heart failure mouse model. Here, HDAC8 is linked to persistent truncus arteriosus.